Skip to main content
. 2018 Sep 10;20(9):e259. doi: 10.2196/jmir.9966

Table 4.

Median scores and significance test results for clinician-reported variables among groups.

Tests Stage 1a (agree)a (n=23), n (%) Stage 1b+ (agree)b (n=26), n (%) Stage 1b+ (disagree)c (n=19), n (%) Significance test Hd (P) Post hoc P values
a vs c b vs c
CGI-Se

Face-to-face, median (IQR)f 2.0 (1) 3.0 (2) 1.0 (1) 37.04 (<.001) .83 <.001

Online, median (IQR) 2.0 (1) 4.0 (1) 3.0 (1) 35.29 (<.001) <.001 .01
SOFASg

Face-to-face, median (IQR) 75.0 (9) 69.0 (15) 75.0 (5) 12.17 (.007) .10 .08

Online, median (IQR) 75.0 (9) 60.0 (10) 71.0 (10) 25.33 (<.001) .01 .003

aStage 1a by online and face-to-face clinicians.

bStage 1b+ by online and face-to-face clinicians.

cStage 1b+ by online clinicians but assessed as stage 1a by face-to-face clinicians.

dKruskal–Wallis test, 2-tailed.

eCGI-S: Clinical Global Impression Scale–Severity.

fIQR: Interquartile range.

gSOFAS: Social and Occupational Functioning Assessment Scale.